AKTIVITAS HESPERIDIN SEBAGAI AGEN KOKEMOTERAPI BERTARGET P-GLIKOPROTEIN DAN IKK UNTUK MENGATASI RESISTENSI PADA SEL MCF-7 RESISTEN DOKSORUBISIN

Doxorubicin is a chemotherapeutic agent used to treat breast cancer, but it induces resistance in some cancers especially in breast cancer. One of the doxorubicin resistance mechanism was resulted from Pgp overexpression, which is an energy dependent pump effluxing xenobiotics out from cells. This s...

Full description

Bibliographic Details
Main Authors: , RIFKI FEBRIANSAH, , Dr. Agung Endro Nugroho, M.Si., Apt
Format: Thesis
Published: [Yogyakarta] : Universitas Gadjah Mada 2012
Subjects:
ETD